EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Engineering nanoplatforms for autoimmune treatment: From synthetic strategies to bioinspired designs

Yihan Wang, Celine Ninsuvannakul, Gloria Zhang, Shiseido Robinson, Mohammad Mahdi Hasani-Sadrabadi

Journal of Controlled Release · 2026-08 · 396 · 115083

DOI: 10.1016/j.jconrel.2026.115083 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Controlled Release, 2026-08. Verfasst von Yihan Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Sibley School of Mechanical and Aerospace Engineering, Cornell University, Ithaca, New York 14850, United States. Hauptthemen laut MEDLINE: Autoimmune Diseases, Nanoparticles. Die Arbeit nennt 332 Literaturangaben. Gefördert von: Cornell University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autoimmune diseases encompass a diverse group of disorders with distinct clinical manifestations but a unifying defect, the breakdown of immune self-tolerance that drives dysregulated immune activation. Current therapies broadly suppress immunity rather than reestablishing regulatory balance and therefore provide limited and often transient control. Building on recent advances in nanomedicine, we introduce an immunoengineering framework that restores immune balance by delivering antigens, co-signals, and tissue repair cues with spatial and temporal precision. This review systematically examines synthetic (liposomes, polymeric nanoparticles, 2D materials), biologically derived and bioinspired (extracellular vesicles, bacterial/viral and cell-membrane vesicles), and hybrid systems, outlining design rules including size and shape, surface chemistry and ligand valency, cargo architecture, and stimuli responsiveness, that govern biodistribution, cellular uptake, and immune programming. Mechanistic principles are illustrated across distinct contexts (e.g., alloantigen responses, mucosal barrier failure, β-cell autoimmunity), emphasizing strategies that induce antigen-specific tolerance, reprogram innate compartments, and repair barriers while preserving protective immunity. We also map key translational needs: standardized characterization and potency assays, long-term safety and biodistribution, scalable manufacturing, regulatory fit, and cost-effectiveness. Together, these insights provide a blueprint for precision nanomedicine to move autoimmunity treatment from blanket suppression toward durable, mechanism-based remission.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autoimmune DiseasesNanoparticlesAnimalsHumansNanomedicine

Stichwörter der Autor:innen

Autoimmune diseaseBioinspired nanoplatformsImmune toleranceImmunoengineeringNanomedicine

Autor:innen und Institutionen

  • Sibley School of Mechanical and Aerospace Engineering, Cornell University, Ithaca, New York 14850, United States.
  • Sibley School of Mechanical and Aerospace Engineering, Cornell University, Ithaca, New York 14850, United States. Electronic address: mh2558@cornell.edu.

Förderung

  • Cornell University

Zitieren

APA

Wang, Y., Ninsuvannakul, C., Zhang, G., Robinson, S., & Hasani-Sadrabadi, M. M. (2026). Engineering nanoplatforms for autoimmune treatment: From synthetic strategies to bioinspired designs. Journal of Controlled Release, 396, 115083. https://doi.org/10.1016/j.jconrel.2026.115083

Vancouver

Wang Y, Ninsuvannakul C, Zhang G, Robinson S, Hasani-Sadrabadi MM. Engineering nanoplatforms for autoimmune treatment: From synthetic strategies to bioinspired designs. Journal of Controlled Release. 2026;396:115083. doi:10.1016/j.jconrel.2026.115083

BibTeX
@article{Wang2026,
  author = {Wang, Yihan and Ninsuvannakul, Celine and Zhang, Gloria and Robinson, Shiseido and Hasani-Sadrabadi, Mohammad Mahdi},
  title = {Engineering nanoplatforms for autoimmune treatment: From synthetic strategies to bioinspired designs},
  journal = {Journal of Controlled Release},
  year = {2026},
  volume = {396},
  pages = {115083},
  doi = {10.1016/j.jconrel.2026.115083}
}
Kostenlos starten →